CRBP peer analysis
Corbus (CRBP) against its competitors: price, today's move, 1-year return and market value side by side.
CRBP and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALEC Alector | $2.09 | -2.79% | 42.18% | $240.06M |
| CRDF Cardiff Oncology | $0.84 | -5.09% | -64.07% | $65.68M |
| ELTX Elicio | $1.59 | -5.36% | -82.88% | – |
| IPHA Innate Pharma | $1.40 | -4.11% | -41.18% | $156.38M |
| MIST Milestone Pharmaceuticals | $0.72 | -1.22% | -62.44% | $89.78M |
| MOLN Molecular Partners | $3.48 | -6.22% | – | – |
| PEPG PepGen | $2.43 | 3.40% | -47.85% | – |
| RANI Rani Therapeutics | $0.55 | -6.47% | -74.92% | – |
| CRBP Corbus | $3.84 | -1.92% | -68.40% | $75.72M |
- CRBP's peers: ALEC (Alector), CRDF (Cardiff Oncology), ELTX (Elicio), IPHA (Innate Pharma), MIST (Milestone Pharmaceuticals), MOLN (Molecular Partners), PEPG (PepGen), RANI (Rani Therapeutics).
Updated 2026-11-03 23:16 UTC